PUBLISHER: The Business Research Company | PRODUCT CODE: 2098842
PUBLISHER: The Business Research Company | PRODUCT CODE: 2098842
Revision knee replacement is an orthopedic surgical procedure carried out to remove and substitute a failed, damaged, or worn knee implant that was implanted during a prior knee replacement surgery. It is generally necessary because of issues including infection, implant loosening, instability, or material wear and requires more advanced surgical approaches than those used in primary knee replacement operations.
The primary product types of revision knee replacement include three compartmental systems and unicompartmental systems. Three compartmental systems refer to revision knee implant solutions engineered to substitute or reconstruct all the major compartments of the knee joint during revision surgical procedures. These systems are offered with fixation options including cemented revision systems, cementless revision systems, and hybrid fixation systems. They are applied in conditions such as aseptic loosening and infection and are utilized by end users including hospitals, orthopedic clinics, and ambulatory surgical centers.
Tariffs are influencing the revision knee replacement market by increasing costs of imported orthopedic implants, fixation systems, surgical instruments, and advanced biomaterials used in revision procedures. This is elevating procedural expenditures and creating procurement challenges for healthcare providers, particularly in regions dependent on imported medical devices such as Asia-Pacific and Latin America. Implant-intensive categories, including cementless revision systems, hybrid fixation systems, and hinged revision knee systems, are most affected due to reliance on global supply networks. However, tariffs are also prompting local manufacturing development, supplier diversification, and increased investment in domestic orthopedic device production, enhancing long-term market resilience.
The revision knee replacement market size has grown steadily in recent years. It will grow from $1.4 billion in 2025 to $1.47 billion in 2026 at a compound annual growth rate (CAGR) of 4.9%. The growth in the historic period can be attributed to aging population driving higher revision surgery volumes, increasing occurrence of implant loosening complications, rising volume of primary knee replacement surgeries, greater awareness of revision treatment alternatives, improvements in surgical techniques for complex revision cases.
The revision knee replacement market size is expected to see steady growth in the next few years. It will grow to $1.68 billion in 2030 at a compound annual growth rate (CAGR) of 3.4%. The growth during the forecast period can be attributed to growing adoption of personalized revision implant solutions, increasing demand for infection-resistant implant technologies, rising utilization of robotic-assisted revision surgical procedures, expansion of outpatient-based revision knee surgeries, and development of next-generation durable implant materials. Major trends expected in the forecast period include wider adoption of revision-specific knee implant designs, growing demand for durable and wear-resistant knee systems, increasing use of patient-matched implants in complex revision surgeries, expansion of advanced biomaterial utilization in revision procedures, and heightened focus on infection-resistant revision implant technologies.
The rising prevalence of obesity and lifestyle-related diseases is expected to drive the growth of the revision knee replacement market going forward. Obesity and lifestyle-related diseases refer to long-term health conditions such as diabetes, cardiovascular disorders, and musculoskeletal issues that develop due to unhealthy dietary habits, lack of physical activity, excessive body weight, and sedentary lifestyles. The increasing prevalence of obesity and lifestyle-related diseases is rising due to reduced physical activity and higher intake of calorie-dense processed foods among urban populations. Revision knee replacement supports patients with obesity and lifestyle-related diseases by replacing failed or worn knee implants, restoring mobility, alleviating chronic pain, and improving long-term joint function following complications from primary knee replacement procedures. For instance, in May 2025, according to the Office for Health Improvement and Disparities, a UK-based government organization, 64.5% of adults in England were overweight or living with obesity in 2023 to 2024, compared to 64.0% in 2022 to 2023. Therefore, the rising prevalence of obesity and lifestyle-related diseases is driving the growth of the revision knee replacement market.
Leading companies operating in the revision knee replacement market are focusing on expanding advanced revision knee implant systems, such as modular revision knee platforms, to improve implant fixation, joint stability, and surgical flexibility in complex knee reconstruction procedures. Modular revision knee platforms refer to specialized knee replacement systems designed for revision arthroplasty that allow surgeons to customize components, stems, augments, and fixation options according to bone loss severity and patient anatomy. For example, in November 2024, Zimmer Biomet Holdings Inc., a US-based medical technology company, received CE Mark certification and expanded the commercial launch of the Persona Revision Knee System for revision knee arthroplasty procedures. The system features personalized anatomical implant design, modular component options for complex revision cases, advanced fixation capabilities for bone defect management, and compatibility with modern surgical workflow technologies to support implant stability and procedural efficiency.
In January 2024, Enovis Corporation, a US-based medical technology company focused on orthopedic reconstruction and rehabilitation solutions, acquired LimaCorporate S.p.A. for an undisclosed amount. With this acquisition, Enovis aimed to strengthen its orthopedic implant and joint reconstruction portfolio by expanding its capabilities in advanced knee reconstruction systems and revision arthroplasty technologies. LimaCorporate S.p.A. is an Italy-based orthopedic implant manufacturer specializing in revision knee replacement systems, joint reconstruction implants, and customized orthopedic solutions.
Major companies operating in the revision knee replacement market are Stryker Corporation, Zimmer Biomet Holdings Inc., Johnson&Johnson, Smith & Nephew plc, Enovis Corporation, B. Braun Melsungen AG, Medacta International SA, Waldemar Link GmbH & Co. KG, MicroPort Scientific Corporation, AK Medical Holdings Limited, Beijing Chunlizhengda Medical Instruments Co. Ltd., Corin Group, United Orthopedic Corporation, Peter Brehm GmbH, Meril Life Sciences Pvt. Ltd., Biorad Medisys, Ortho Development Corporation, Maxx Orthopedics, Surgival International, Baumer S.A., Beznoska s.r.o.
North America was the dominant region in the revision knee replacement market in 2025. Asia-Pacific is expected to be the rapidly expanding region in the forecast period. The regions covered in revision knee replacement report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the revision knee replacement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The revision knee replacement market consists of sales of revision knee implants, revision femoral components, revision tibial components, patellar components, and stem extensions. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The revision knee replacement market research report is one of a series of new reports from The Business Research Company that provides revision knee replacement market statistics, including revision knee replacement industry global market size, regional shares, competitors with a revision knee replacement market share, detailed revision knee replacement market segments, market trends and opportunities, and any further data you may need to thrive in the revision knee replacement industry. This revision knee replacement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Revision Knee Replacement Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses revision knee replacement market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for revision knee replacement ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The revision knee replacement market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.